GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ryvu Therapeutics SA (WAR:RVU) » Definitions » 12-1 Month Momentum %

Ryvu Therapeutics (WAR:RVU) 12-1 Month Momentum % : -14.05% (As of Jun. 17, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Ryvu Therapeutics 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-06-17), Ryvu Therapeutics's 12-1 Month Momentum % is -14.05%.

The industry rank for Ryvu Therapeutics's 12-1 Month Momentum % or its related term are showing as below:

WAR:RVU's 12-1 Month Momentum % is ranked better than
57.22% of 1482 companies
in the Biotechnology industry
Industry Median: -23.015 vs WAR:RVU: -14.05

Competitive Comparison of Ryvu Therapeutics's 12-1 Month Momentum %

For the Biotechnology subindustry, Ryvu Therapeutics's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ryvu Therapeutics's 12-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ryvu Therapeutics's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Ryvu Therapeutics's 12-1 Month Momentum % falls into.



Ryvu Therapeutics  (WAR:RVU) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ryvu Therapeutics  (WAR:RVU) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Ryvu Therapeutics 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Ryvu Therapeutics's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ryvu Therapeutics (WAR:RVU) Business Description

Traded in Other Exchanges
Address
Leona Henryka Sternbacha 2, Krakow, POL, 30-394
Ryvu Therapeutics SA is a company which is engaged in discovering and developing small molecule therapies that address oncology. Its product candidate SEL120, is a kinase inhibitor with potential for development in hematological malignancies and solid tumors. The pipeline products of the company are developed in the areas of kinases, cancer metabolism, synthetic lethality, and immuno-oncology pathways.

Ryvu Therapeutics (WAR:RVU) Headlines

No Headlines